Full name
LIVANOVA POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.6 - Wholesale trade of other machines, devices, and additional equipment
46.75.Z - Wholesale trade
47.74.Z - Retail sale of medical and orthopedic products
47.78.Z - Retail sale of other new products
47.91.Z - Intermediary retail sale, non-specialized
47.99.Z - Retail trade
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 4,8 | 3,4 | 8,1 | 134,5 |
EBITDA | 4,7 | 3 | 7,4 | 149 |
Short time liabilities | 2,7 | 2,5 | 2,8 | 12,2 |
Equity capital | 12,2 | 14,5 | 21 | 44,3 |
Operating profit (EBIT) | 4,7 | 3 | 7,4 | 147,6 |
Assets | 15,6 | 18,8 | 25,9 | 37,6 |
Net profit (loss) | 3,8 | 2,7 | 6,4 | 137,5 |
Cash | 6,4 | 0,8 | 5,7 | 650,4 |
Net income from sale | 24 | 25,4 | 33,3 | 30,8 |
Liabilities and provisions for liabilities | 3,4 | 4,2 | 4,9 | 14,6 |
Working assets | 15,4 | 18,4 | 25,4 | 38,1 |
Depreciation | -0 | -0 | -0 | 41,2 |
% | % | % | p.p. | |
Profitability of capital | 31,1 | 18,7 | 30,7 | 12 |
Equity capital to total assets | 78,2 | 77,4 | 81,2 | 3,8 |
Gross profit margin | 19,8 | 13,5 | 24,2 | 10,7 |
EBITDA Margin | 19,6 | 11,7 | 22,2 | 10,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 42 | 35 | 30 | -5 |
Current financial liquidity indicator | 4.527187347412109 | 5.035998344421387 | 6.061634540557861 | 1,1 |
Net dept to EBITDA | -1.3536978960037231 | -0.21959376335144043 | -0.7601963877677917 | -0,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane